124 related articles for article (PubMed ID: 3082095)
1. No effect of treatment with sodium valproate on plasma growth hormone in bromocriptine unresponsive acromegaly.
Nortier JW; Croughs RJ; Schwarz F; Thijssen JH
Acta Endocrinol (Copenh); 1986 Feb; 111(2):162-4. PubMed ID: 3082095
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutical effects of bromocriptine (CB 154) in 10 acromegalic subjects. Study of somatotrophic function and clinical survey (author's transl)].
Fossati P; Asfour M; Brion-Brevan B; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA; Blacker C
Ann Endocrinol (Paris); 1977; 38(4):291-301. PubMed ID: 332054
[TBL] [Abstract][Full Text] [Related]
3. Changes of molecular forms of growth hormone in bromocriptine treated acromegaly in relation to changes of somatomedin-C and clinical response.
Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1985 Feb; 108(2):145-50. PubMed ID: 4038567
[TBL] [Abstract][Full Text] [Related]
4. Long-term bromocriptine therapy and predictive tests in acromegaly.
Karashima T; Kato K; Nawata H; Ikuyama S; Ibayashi H; Okamura K; Shiroozu A; Nakashima T; Fujishima M
Endocrinol Jpn; 1986 Apr; 33(2):163-7. PubMed ID: 3093202
[TBL] [Abstract][Full Text] [Related]
5. A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs.
Lamberts SW; Zweens M; Verschoor L; del Pozo E
J Clin Endocrinol Metab; 1986 Jul; 63(1):16-9. PubMed ID: 2872225
[TBL] [Abstract][Full Text] [Related]
6. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests.
Nortier JW; Croughs RJ; Thijssen JH; Schwarz F
Clin Endocrinol (Oxf); 1984 May; 20(5):565-71. PubMed ID: 6744634
[TBL] [Abstract][Full Text] [Related]
7. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term treatment with bromocriptine on the growth hormone response to galanin in patients with acromegaly.
Giustina A; Doga M; Bussi AR; Licini M; Schettino M
Acta Endocrinol (Copenh); 1993 Feb; 128(2):131-5. PubMed ID: 7680832
[TBL] [Abstract][Full Text] [Related]
9. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly.
Chiba T; Chihara K; Minamitani N; Goto B; Kadowaki S; Taminato T; Matsukura S; Fujita T
Horm Metab Res; 1982 Feb; 14(2):57-61. PubMed ID: 7040191
[TBL] [Abstract][Full Text] [Related]
10. Effect of the acute administration of haloperidol and pimozide on plasma GH levels in acromegaly.
Carmina E; Lo Coco R; Lanzara P; Jannì A
Acta Endocrinol (Copenh); 1979 Aug; 91(4):609-15. PubMed ID: 115193
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acromegaly with bromocriptine.
Steinbeck K; Turtle JR
Med J Aust; 1978 Nov; 2(3 Suppl):35-6. PubMed ID: 745581
[TBL] [Abstract][Full Text] [Related]
12. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests.
Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1984 Jun; 106(2):175-83. PubMed ID: 6145276
[TBL] [Abstract][Full Text] [Related]
13. Experiences with bromocriptine treatment in acromegaly--a preliminary report.
Nilsson A
Acta Endocrinol Suppl (Copenh); 1978; 216():217-24. PubMed ID: 274038
[TBL] [Abstract][Full Text] [Related]
14. The effect of bromocriptine on insulin secretion and glucose tolerance in patients with acromegaly.
Feek CM; Bevan JS; Taylor S; Brown NS; Baird JD
Clin Endocrinol (Oxf); 1981 Nov; 15(5):473-8. PubMed ID: 7035013
[TBL] [Abstract][Full Text] [Related]
15. Measurement of the 24 hour integrated plasma concentration of growth hormone, in assessing the response of acromegalic patients to treatment.
Daggett PR; Nabarro JD
Clin Endocrinol (Oxf); 1977 Dec; 7(6):437-41. PubMed ID: 563781
[TBL] [Abstract][Full Text] [Related]
16. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
[TBL] [Abstract][Full Text] [Related]
17. Bomocriptine treatment of patients with acromegaly resistant to conventional therapy.
Pelkonen R; Ylikahri R; Karonen SL
Clin Endocrinol (Oxf); 1980 Mar; 12(3):219-24. PubMed ID: 6993053
[TBL] [Abstract][Full Text] [Related]
18. The influence of bromocriptine on serum levels of growth hormone and other pituitary hormones and its metabolic effects in active acromegaly.
Roelfsema F; Goslings BM; Frölich M; Moolenaar AJ; Seters AP; Van Slooten H
Clin Endocrinol (Oxf); 1979; 11(2):235-44. PubMed ID: 114344
[TBL] [Abstract][Full Text] [Related]
19. No acute effect of pimozide on the plasma GH levels in acromegaly.
Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1983 Aug; 103(4):461-8. PubMed ID: 6613492
[TBL] [Abstract][Full Text] [Related]
20. Bromocriptine suppression of plasma growth hormone in acromegaly.
Dunn PJ; Donald RA; Espiner EA
Clin Endocrinol (Oxf); 1977 Oct; 7(4):273-81. PubMed ID: 336245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
